Contents lists available ScienceDirect IBRO Neuroscience Reports journal homepage wwwsciencedirectcomjournalIBRONeuroscienceReports Do cerebral microbleeds increase risk dementia A systematic review metaanalysis Ahmed Salah Hussein ab Muhammad Shawqi c Eshak I Bahbah d Basma Ragab ae Mohammad Sunoqrot f Ahmed Gadallah g Hazem S Ghaith ab Ahmed Negida hij Medical Research Group Egypt MRGE Cairo Egypt b Faculty Medicine AlAzhar University Cairo Egypt c Faculty Medicine Assiut University Assiut Egypt d Faculty Medicine AlAzhar University Damietta Egypt e Faculty Physical Therapy Cairo University Cairo Egypt f Faculty Medicine Cairo University Cairo Egypt g Ain Shams University Hospitals Cairo Egypt h Faculty Medicine Zagazig University Egypt School Pharmacy Biomedical Sciences University Portsmouth United Kingdom j Department Global Health Social Medicine Harvard Medical School MA USA A R T I C L E I N F O A B S T R A C T Keywords Brain microbleeds Cerebral microbleeds Cognitive decline Dementia Background Dementia neurological disorder commonly affects elderly Cerebral microbleeds CMBs small tiny lesions cerebral blood vessels suggested possible risk factor dementia However data association CMBs dementia risk inconsistent inconclusive Therefore conducted systematic review metaanalysis investigate association CMBs dementia highlight possible explanations Methods We followed standard PRISMA statement Cochrane Handbook guidelines conduct study First searched medical electronic databases relevant articles Then screened retrieved articles eligibility extracted relevant data appraised methodological quality Newcastle Ottawa Scale Finally extracted data pooled risk ratios RR hazard ratios HR random effects metaanalysis model Review Manager software Results We included studies 14221 participants followup periods 18 months Overall CMBs significantly increased risk developing dementia RR 184 95 CI 127265 This association significant subgroups studies highrisk populations RR 200 95 CI 141283 n 1657 par ticipants general population RR 230 95 CI 125426 n 12087 participants memory clinic patients Further CMBs increased risk progressing incident dementia time HR 2 95 CI 154261 Conclusion Individuals CMBs twice risk developing dementia progressing MCI CMBs The detection CMBs help identify population higher risk developing dementia Physicians educate individuals CMBs families possibility progressing dementia MCI Regular cognitive assessments cognitive training lifestyle modifications controlling dementia risk factors recommended individuals CMBs decrease risk cognitive decline dementia development 1 Introduction Dementia neurological disorder includes cognitive deterio ration memory thinking social abilities problemsolving ability personal behavior changes Chertkow et al 2013 Symptoms mentia include emotional disturbances language problems symptoms interfere patients daily activity Chert kow et al 2013 Dementia classified subtypes Correspondence Harvard Medical School 641 Huntington Avenue Boston MA 02115 USA Email addresses ahmed_negidahmsharvardedu ahmedsaidnegidagmailcom A Negida httpsdoiorg101016jibneur202212009 Received 14 May 2022 Accepted 26 December 2022 IBRONeuroscienceReports1420238694Availableonline28December2022266724212022TheAuthorsPublishedbyElsevierLtdonbehalfofInternationalBrainResearchOrganizationThisisanopenaccessarticleundertheCCBYNCNDlicensehttpcreativecommonsorglicensesbyncnd40 AS Hussein et al according presentations etiology The common types mentia Alzheimers disease AD dementia representing 56 vascular dementia representing 11 mixed dementia representing 21 Alladi et al 2011 Wu et al 2018 According World Health Organization Alzheimers disease International new case dementia develops seconds Globally prevalence dementia 468 million 2015 numbers expected increase time Furthermore mentia patients live low middleincome countries ADI 2022 Therefore addressing dementia neurological priority global health dimension Primary prevention key decreasing global burden mentia Therefore identifying risk factors dementia essential neurologists neurosurgeons public health experts One risk factors reported dementia cerebral Microbleeds CMBs defined small rounded tiny lesions cerebral blood vessels Akoudad et al 2016 Romero et al 2017 MartinezRamirez et al 2014 Ding et al 2017 CMBs represent blood degradation products small blood vessels They visualized classic magnetic reso nance imaging MRI gradientecho sequences MRI sensitivity Kim Lee 2013 CMBs indicators underlying small vessel disease SVD strong association conditions severe hypertension indicator endorgan damage cere bral amyloid angiopathy cerebral infarcts Greenberg et al 2009 Other uncommon causes CMBs include infective endocarditis thrombotic thrombocytopenic purpura postradiation therapy revers ible encephalopathy syndrome traumatic brain injury moyamoya dis ease sickle cell anemia Î²thalassemia obstructive sleep apnea NoorbakhshSabet et al 2017 Multiple studies examined association CMBs risk dementia reported conflicting results difference followup period outcome measures risk factors number included patientsparticipants For example Romero et al 2017 ported significant association Romero et al 2017 studies support association Benedictus et al 2015 Stae kenborg et al 2009 Given literature data inconsistent inconclusive conducted systematic review metaanalysis synthesize evidence published prospective cohort studies association CMBs development dementia 2 Materials methods The study conducted according guidelines Preferred Reporting Items Systematic Reviews MetaAnalyses PRISMA statement Cochrane Handbook Systematic Re views Interventions Page et al 2021 Moher et al 2009 Higgins et al 2019 21 Search strategy We searched MEDLINE PubMed SCOPUS Web Science Global Health Library databases potentially relevant studies December 2019 search terms created searching Med ical Subject Headings MeSH terms paper published Charidimou et al 2018 Charidimou et al 2018 microbleed OR microhemorrhag OR microhemorrhag OR dotlike AND MRI OR SWI OR T2 OR suscept OR hemosid AND brain OR cerebr OR cerebral small vessel disease OR vascular dementia OR Alzheimer dis ease OR Alzheimers disease OR cognit OR dement The identified citations retrieved imported Endnote X8 software package Thompson Reuter USA The title abstract retrieved papers screened according predefined eligibility criteria independent review authors MS BR AG MS reviewed text eligibility Then results possible eligible studies reviewed author ASH independently final list included studies decided discussion consensus 22 Eligibility criteria Studies satisfying prespecified PIOS criteria included systematic review follows 1 Population studies conducted general population highrisk population patients memory clinics 2 Indicator studies indicator presence CMBs detected MRI standard criteria baseline predictor risk factor sufficient followup periods development dementia outcome 3 Outcome studies outcome develop ment dementia major subtype 4 Study design studies design observational prospective cohort studies limitation age gender participants We excluded studies following reasons 1 Different study designs case reports crosssectional studies review papers 2 Studies enrolled patients AD baseline 3 Studies report atypical AD 4 Studies included mixed groups AD mild cognitive impair ment MCI 5 Conference abstracts available fulltext articles 6 Studies data reliable extraction analysis 7 Studies reporting multiple outcomes including dementia separate data provided dementia outcome separately 23 Outcome measures The primary outcome development dementia AD dementia measured repeated neuropsychological clinical eval uation Benedictus et al 2015 van Uden et al 2016 MiniMental State Examination MMSE Romero et al 2017 Ding et al 2017 Miwa et al 2016 2014 scores 24 comprehensive battery cognitive testing Romero et al 2017 geriatric mental schedule Akoudad et al 2016 While secondary outcome devel opment incident dementia time 24 Data extraction Four review authors MS BR AG MS extracted required data independently review author ASH resolved conflicts We extracted following data study study design number participants baseline characteristics including age sex body mass index followup period education level vascular risk fac tors including hypertension smoking diabetes hyperlipidemia apolipoprotein E APOE gene status baseline MMSE Data retrieved included studies entered combined excel file containing requested data categories studys quality evaluated NOSs criteria Most baseline data presented units measures mean SD range Additionally MMSE vascular risk variables consistent studies mean SD n The following procedures carried the1ry 2ry outcomes 1 Dividing study arms Controlled CMBs Experi mental No CMBs IBRONeuroscienceReports142023869487 AS Hussein et al 2 Next study calculated incidence dementia proportion patients experienced episodes overall number participants research arm population asymptomatic patients 28 Assessing heterogeneity 25 Quality assessment included studies We assessed methodological quality study terms domains selection comparability outcome described Newcastle Ottawa scale NOS Peterson et al 2011 The selection domain includes items assess representativeness selected cohort integrity selection process The compa rability domain formed item examining confounders adjustments Finally outcome domain includes items assess quality outcome measures adequacy followup period 26 Data synthesis analysis The metaanalysis performed Review Manager RevMan version 53 We random effect model inverse variance method metaanalysis The association CMBs development dementia expressed Risk Ratios RR corresponding 95 confidence intervals CI For studies reporting risk progression incident allcause dementia time effect size pooled HRs corresponding 95 CI We examined statistical heterogeneity inconsistency studies visual inspection forest plot I square test I2 We classified values I2 test follows 25 low degree 25 50 moderate degree 50 high degree heterogeneity Additionally Funnel plots detect possibility publication bias metaanalysis 3 Results 31 Study selection We identified 1965 citations search databases deducted 1601 citations removing duplicates Endnote X8 software package Thompson Reuter USA Based title abstract screening additional 1582 citations meet inclusion criteria excluded For remaining 19 abstracts fulltext articles retrieved evaluated eligibility Of remaining 19 studies studies 14221 patients eligible inclusion systematic review Results search study selection steps shown PRISMA flow diagram Fig 1 27 Subgroup analysis We conducted subgroup analysis according type study population 1 studies patients attending memory clinic 2 studies highrisk population 3 studies general We classified included studies based type study population Two included studies included memory clinics pa tients n 486 participants Benedictus et al 2015 Staekenborg et al 2009 studies conducted highrisk populations n 1657 32 Baseline characteristics included studies Fig 1 The PRISMA flow diagram study selection process IBRONeuroscienceReports142023869488 AS Hussein et al participants van Uden et al 2016 Miwa et al 2016 2014 remaining studies enrolled participants general population n 12087 participants Akoudad et al 2016 Romero et al 2017 Ding et al 2017 Kirsch et al 2009 All included studies published 2009 2017 Overall 14221 participants enrolled studies sample sizes ranging 23 3911 par ticipants study The mean age participants 70 years followup period studies 18 months Detailed charac teristics included studies populations shown Table 1 33 Risk bias quality evidence assessment The quality score NOS good included studies score 7 8 9 The participants exposed cohort repre sentative communities studies Other age sex studies controlled factors medial temporal lobe atrophy education baseline MMSE APOE status vascular risk factors total cholesterol level The followup periods 18 months studies long event dementia develop participants completed followup period The results quality assessment shown Table 2 34 Metaanalysis association CMBs dementia The metaanalysis memory clinic studies 486 participants highrisk studies 1657 participants studies general population 8820 participants These included studies provided relevant data association CMBs development dementia The overall metaanalysis subgrouping showed individuals CMBs Table 1 Baseline characteristics included studies population n Number participants FU followup period APOE Apolipoprotein E MMSE minimental state examination Study Study arms n Female Age mean SD Range FU period years mean SD Vascular risk factors Hypertension n Smokers n Diabetes n Hyperlipidemia n Stable 281 61 9 48 3 2 83 29 24 8 54 19 Progressors Dementia 53 42 Nondement 458 No CMB 1156 69 7 746 65 648 85 71 8 42 43 42 4 3 52 07 21 40 ÙÙÙÙ ÙÙÙÙ 66 68 27 717 62 69 6 150 13 CMB 140 76 7 45 58 28 107 76 9 6 24 17 ÙÙÙÙ ÙÙÙÙ ÙÙÙÙ ÙÙÙÙ Benedictus 2015 Van Uden 2015 Romero 2017 Akoudad 2016 Miwa 2015 Miwa 2014 MBs absent Cognitive decline analysis MBs present Cognitive decline analysis MBs absent Incident dementia analysis MBs present Incident dementia analysis tHcy 92 mol L tHcy 92 mol L No CMBs CMBs staekenborg Nonconverters 2009 Kirsch 2009 Converters Normal MCI Demented Ding 2017 NoCMBs 1 CMB 2 CMBs 3 CMBs 2780 477 590 76 628 85 3911 624 104 930 698 717 328 315 401 113 80 72 33 23 26 2165 311 68 58 654 83 69 81 673 81 681 88 68 9 72 7 712 5484 755 6487 789 6788 745 48 754 47 754 44 754 47 4 7 ÙÙÙÙ ÙÙÙÙ 210 76 37 78 330 84 16 30 ÙÙÙÙ ÙÙÙÙ ÙÙÙÙ ÙÙÙÙ ÙÙÙÙ ÙÙÙÙ ÙÙÙÙ 98 105 ÙÙÙÙ 55 48 14 1446 520 5280 5550 ÙÙÙÙ ÙÙÙÙ 297 623 2304 589 5290 ÙÙÙÙ 678 729 1900 683 351 736 2706 692 678 729 54 73 32 237 72 32 98 76 23 186 57 28 ÙÙÙÙ 271 86 69 21 96 30 197 62 44 7 26 294 73 67 17 96 24 265 66 31 ÙÙÙÙ 94 83 18 16 27 24 67 59 39 18 11 56 5760 22 13 28 098 3480 216 1 5380 6150 4820 4410 6320 223 104 52 02 ÙÙÙÙ ÙÙÙÙ ÙÙÙÙ ÙÙÙÙ ÙÙÙÙ ÙÙÙÙ ÙÙÙÙ ÙÙÙÙ ÙÙÙÙ ÙÙÙÙ ÙÙÙÙ ÙÙÙÙ ÙÙÙÙ ÙÙÙÙ ÙÙÙÙ ÙÙÙÙ ÙÙÙÙ ÙÙÙÙ 1651 763 256 823 230 107 30 97 197 91 29 94 59 868 10 147 5 74 52 897 6 103 10 172 ÙÙÙÙ ÙÙÙÙ ÙÙÙÙ ÙÙÙÙ ÙÙÙÙ ÙÙÙÙ ÙÙÙÙ ÙÙÙÙ ÙÙÙÙ APOE state n Any Îµ4 allele ÙÙÙÙ ÙÙÙÙ ÙÙÙÙ ÙÙÙÙ 243 21 37 26 735 282 141 314 884 286 233 320 53 21 53 21 78 19 23 20 ÙÙÙÙ ÙÙÙÙ ÙÙÙÙ ÙÙÙÙ ÙÙÙÙ 555 257 78 251 26 382 26 362 Baseline MMSE mean SD 28 2 28 2 271 17 282 16 ÙÙÙÙ ÙÙÙÙ ÙÙÙÙ ÙÙÙÙ ÙÙÙÙ ÙÙÙÙ 283 16 282 18 282 19 277 20 27 2 26 2 ÙÙÙÙ ÙÙÙÙ ÙÙÙÙ 2775 088 2775 088 2725 088 2725 088 IBRONeuroscienceReports142023869489 AS Hussein et al Table 2 Results risk bias assessment NOS Good quality 3 4 stars selection domain AND 1 2 stars comparability domain AND 2 3 stars outcome domain Fair quality 2 stars selection domain AND 1 2 stars comparability domain AND 2 3 stars outcomeexposure domain Poor quality 0 1 star selection domain OR 0 stars comparability domain OR 0 1 stars outcomeexposure domain Study Selection Representativeness Exposed Cohort Benedictus 2015 Representative Sample includes patients came memory clinic cognitive impairment Van Uden 2015 Representative sample shows nondemented participants age 50 85 years baseline Romero 2017 Akoudad 2016 Miwa 2015 Participants truly representative dementiafree Framingham Heart Study Participants truly representative aged 45 years invited undergo home interviews physical laboratory examination The sample truly representative people vascular risk factors Ascertainment exposure Outcome Interest Was Not Present Start Study Selection Non Exposed Cohort Same Source exposed Yes MRI Yes Yes MRI Yes Yes MRI Yes Yes MRI Yes Yes MRI Yes Miwa 2014 The sample truly representative people vascular risk factors Yes MRI Yes Yes MRI Yes Staekenborg 2009 Kirsch 2009 152 participants recruited consecutively MCI patient memory clinic Alzheimer Centre VU University Medical Centre 1348 individuals local communities screened recruit Comparability Outcome Comparability Cohorts Assessment outcome Followup long outcomes occur FU 2 years Quality Score Adequacy followup Study adjusted age sex medial temporal lobe atrophy magnetic resonance imaging field strength Cox proportional hazard model Age gender education baseline MMSE Hippocampal volume adjusted Cox proportional hazard model Age sex APOE status education vascular risk factors adjusted multivariable models Age sex education Additionally APOE Îµ4 propensity score cardiovascular risk adjusted regression models Age gender BMI MMSE smoking hypertension previous CVDs adjusted Logistic regression model Age sex education APOE status adjusted Cox proportional hazards regression model Age sex adjusted Cox Regression model Yes Independent blind assessment Good 79 completed 1year followup neuropsychological assessment Yes Independent blind assessment Good 90 participated 5years follow description lost participants Yes Independent blind assessment Yes Independent blind assessment Good Good 126 participants excluded lack follow information second data collection rest participants complete study Followup dementia completed 4841 participants Record Yes Complete followup participants Good Record Yes Complete followup participants Good Record Yes Good All patients annually reexamined possible alteration cognitive function mean followup 1 2 years Yes MRI Yes Age presence BMB adjusted Record Yes Complete followup participants Good continued page IBRONeuroscienceReports142023869490 AS Hussein et al Table 2 continued Study Selection Representativeness Exposed Cohort Ding 2017 elderly cognitively normal mild cognitively impaired MCI study participants 2602 representative participants aged 6693 years free prevalent dementia Ascertainment exposure Outcome Interest Was Not Present Start Study Selection Non Exposed Cohort Same Source exposed Comparability Outcome Comparability Cohorts Assessment outcome Followup long outcomes occur FU 2 years Quality Score Adequacy followup Yes MRI Yes logistic regression model Age sex follow time interval coil type primary education hypertension total cholesterol adjusted logistic regression model Record Yes Good 98 participants attended followup assessment provided description lost associated overall 184 times increased risk developing dementia CMBs RR 184 95 CI 127265 P 0001 Fig 2 In subgroup metaanalysis memory clinic studies Benedictus et al 2015 Staekenborg et al 2009 showed associa tion CMBs development dementia statistical heterogeneity studies RR 102 95 CI 068151 P 094 On hand studies highrisk population van Uden et al 2016 Miwa et al 2016 2014 showed doublefold increase risk dementia CMBs RR 200 95 CI 141283 P 00001 statistical heterogeneity I2 0 P 055 The remaining studies general population Akoudad et al 2016 Romero et al 2017 Ding et al 2017 Kirsch et al 2009 showed increase risk dementia CMBs RR Fig 2 Forest plot showing risk dementia CMBs CMBs groups expressed risk ratio 95 CI CMBsCerebral Microbleeds IVInverse Variance CIConfidence Interval IBRONeuroscienceReports142023869491 AS Hussein et al 230 95 CI 125426 P 0001 substantial statistical heterogeneity I2 77 P 00001 The results metaanalysis shown Fig 2 concordant primary crude analysis event rates represented RRs secondary analysis incident dementia time expressed adjusted HRs 35 Metaanalysis hazard ratios incident dementia time 42 Explanation study findings Unlike primary analysis studies reported adjusted HR incident dementia time followup When effect estimates pooled metaanalysis model statisti cally significant association CMBs allcause dementia HR 2 95 CI 154261 P 00001 heterogeneity included studies I2 0 Additionally subgroups studies highrisk patients general population showed similar significant associations pooled adjusted HR 163 219 significant heterogeneity subgroups I2 0 The subgroup memory clinic population represented analysis memory clinic studies Benedictus et al 2015 Staekenborg et al 2009 report adjusted HR estimated extracted studies included secondary analysis The results metaanalysis adjusted HRs shown Fig 3 36 Publication bias According Egger et al 1997 assessment publication bias funnel plot Eggers test reliable metaanalysis fewer included studies Therefore present study confirm existence publication bias For explan atory purpose funnel plot metaanalysis model primary outcome provided supplementary file 1 By visual inspection distribution studies effect estimate suggest existence publication bias 4 Discussion 41 Summary key findings This metaanalysis showed individuals CMBs twice risk dementia compared CMBs These results evident subgroups studies highrisk populations general population asymptomatic individuals studies memory clinic patients In addition results CMBs indicator underlying pathology SVD Greenberg et al 2009 direct impact CMBs cognitive brain functions fully understood The literature provides possible explanations association CMBs dementia fol lows First CMBs contribute network disruption tissue damage early cognitive decline patients early AD Heringa et al 2014 Werring et al 2004 Second CMBs affect cognitive function mainly underlying brain microangiopathy vasculopathy change according number locations Poels et al 2012 Finally CMBsassociated hypertensive vascul opathy amyloid angiopathy accelerate process cognitive deterioration In subgroup memory clinic patients association CMBs dementia statistically significant This explained 1 relatively smaller sample subgroup n 486 patients compared highrisk general population subgroups n 1457 8820 participants respectively 2 shorter follow period Staekenborg et al 2009 average18 years compared studies shorter followup period sufficient dementia manifest 3 Staekenborg et al 2009 report participants baseline vascular risk factors These factors ported studies important risk factors dementia hy pertension Skoog et al 1996 Starr et al 1993 Bellew et al 2004 smoking Shinton Beevers 1989 Ott et al 1998 Merchant et al 1999 Tyas et al 2003 diabetes Brands et al 2005 Young et al 2006 hyperlipidemia Maki et al 2005 Evans et al 2000 Moroney et al 1999 4 Both studies memory clinic subgroup report baseline APOE status participants unlike groups APOE considered principal risk factor dementia development Saunders et al 1993 Blacker et al 1997 Martins et al 2005 Duron Hanon 2008 5 Different outcome measures dementia followup Since studies memory clinic patients report APOE status vascular risk factors confirm participants studies lowered risk dementia compared general population Fig 3 Forest plot showing progression incident dementia causedementia CMBs CMBs groups expressed hazard ratio 95 CI CMBsCerebral Microbleeds IVInverse Variance CIConfidence Interval SEstandard error IBRONeuroscienceReports142023869492 AS Hussein et al 43 Agreement disagreement previous studies Calculating RR HR adjusting age sex significant Our study results agreement Charidimou et al 2018 Jiang et al 2019 Jiang et al 2019 Both studies showed CMBs associated higher risk dementia Still study larger sample size robust analysis reported stronger association Charidimou et al 2018 study Despite sharing included studies Charidimou et al Charidimou et al 2018 included additional studies systematic review increased statistical power analysis Miwa et al 2016 Kirsch et al 2009 Despite validated outcome measure studies discrete outcome measures differ ence followup periods data reporting contribute statistical heterogeneity study results 44 Significance study This study expands literature providing statistically robust evidence CMBs associated dementia progression cognitive decline These results important clinical practice The detection CMBs help identify population higher risk developing dementia Therefore physicians educate patients CMBs families possibility progressing mentia cognitive decline Patients subject regular followup cognitive assessments Further cognitive training lifestyle modifi cations controlling dementia risk factors recom mended individuals CMBs decrease risk cognitive decline 45 Strength points limitations This study strength points 1 followed standard guidelines conducting study PRISMA statement Cochrane Handbook 2 searched multiple electronic databases identify relevant studies 3 analyzed dementia events RR progression incident allcause dementia time HR 4 included studies compared previously published metaanalyses provide larger sample size robust evidence Nonetheless study limitations First included studies heterogeneous baseline characteristics outcome measures Second analyzed data CMBs vs CMBs metaregression number location CMBs Because metaregression analysis requires studies studies report number location CMBs additional analysis feasible conduct Therefore metaanalysis limited small number included studies Because prospective cohort studies dementia require long followup period expensive time money In addition included studies reported effect size progression cause dementia 46 Recommendations future research We recommend future cohort studies CMBs dementia following characteristics A large sample size following recommendations sample size calculation cohort studies Khaled Fahim Negida 2019 A longer follow period 5 years allow dementia occur Enrolling middleaged population existing studies focused elderly Excluding individuals dementia risk factors balancing risk factors baseline matched design avoid confounding bias risk factors analysis Including progression MCI secondary endpoint Conducting detailed neurocognitive assessment illustrate neurocognitive domains mainly affected CMBs patients Comparing mortality CMBs vs nonCMBs individuals Furthermore future basic science research needed understand pathology CMBs affect cognition This helpful prevention programs 47 Conclusion Individuals CMBs twice risk developing dementia CMBs Physicians educate individuals CMBs families possibility progressing dementia cognitive decline Regular cognitive assessments cognitive training lifestyle modifications controlling dementia risk factors recommended individuals CMBs decrease risk cogni tive decline Ethical approval Not required The study involve human participants animal subjects CRediT authorship contribution statement ASH Contributed search strategy formulation statistical analysis interpretation results manuscript writing tabulation EIB Contributed drafting revising manuscript ASH MS BR AG MS Screened retrieved titles abstracts fulltext screening data extraction revision ROB assessment tabulation HG AN Study concept design study supervision revise draft All authors HG AN participated steps study selection data extraction Conflicts Interest None Acknowledgments None declare Appendix A Supporting information Supplementary data associated article online version doi101016jibneur202212009 References ADI Dementia statistics In Alzheimers Disease International httpswwwalzint orgaboutdementiafactsfiguresdementiastatistics Accessed 25 Apr 2022 Akoudad S Wolters FJ Viswanathan A et al 2016 Association cerebral microbleeds cognitive decline dementia JAMA Neurol 73 934943 httpsdoiorg101001jamaneurol20161017 Alladi S Mekala S Chadalawada SK et al 2011 Subtypes dementia study memory clinic India Dement Geriatr Cogn Disord 32 3238 httpsdoiorg 101159000329862 Bellew KM Pigeon JG Stang PE et al 2004 Hypertension rate cognitive decline patients dementia Alzheimer type Alzheimer Dis Assoc Disord 18 208213 Benedictus MR van Harten AC Leeuwis AE et al 2015 White matter hyperintensities relate clinical progression subjective cognitive decline Stroke 46 26612664 httpsdoiorg101161STROKEAHA115009475 Blacker D Haines JL Rodes L et al 1997 ApoE4 age onset Alzheimers disease NIMH genetics initiative Neurology 48 139147 httpsdoiorg 101212wnl481139 IBRONeuroscienceReports142023869493 AS Hussein et al Brands AMA Biessels GJ Haan EHF et al 2005 The effects type 1 diabetes cognitive performance metaanalysis Diabetes Care 28 726735 httpsdoi org102337diacare283726 Charidimou A Shams S Romero JR et al 2018 Clinical significance cerebral microbleeds MRI comprehensive metaanalysis risk intracerebral hemorrhage ischemic stroke mortality dementia cohort studies v1 Int J Stroke 13 454468 httpsdoiorg1011771747493017751931 Chertkow H Feldman HH Jacova C Massoud F 2013 Definitions dementia predementia states Alzheimers disease vascular cognitive impairment consensus Canadian conference diagnosis dementia Alzheimers Res Ther 5 S2 httpsdoiorg101186alzrt198 Ding J SigurÃ°sson S Jonsson PV et al 2017 Space location cerebral microbleeds cognitive decline dementia community Neurology 88 20892097 httpsdoiorg101212WNL0000000000003983 Duron E Hanon O 2008 Vascular risk factors cognitive decline dementia Vasc Health Risk Manag 4 363381 Miwa K Tanaka M Okazaki S et al 2016 Increased total homocysteine levels predict risk incident dementia independent cerebral smallvessel diseases vascular risk factors J Alzheimers Dis 49 503513 httpsdoiorg103233 JAD150458 Moher D Liberati A Tetzlaff J et al 2009 Preferred reporting items systematic reviews metaanalyses PRISMA statement W64 Ann Intern Med 151 264269 httpsdoiorg10732600034819151420090818000135 Moroney JT Tang MX Berglund L et al 1999 Lowdensity lipoprotein cholesterol risk dementia stroke JAMA 282 254260 httpsdoiorg101001 jama2823254 NoorbakhshSabet N Pulakanti VC Zand R 2017 Uncommon causes cerebral microbleeds J Stroke Cereb Dis 26 20432049 httpsdoiorg101016j jstrokecerebrovasdis201707012 Ott A Slooter AJ Hofman A et al 1998 Smoking risk dementia Alzheimers disease populationbased cohort study Rotterdam Study Lancet 351 18401843 httpsdoiorg101016s0140673697075417 Egger M Smith G Schneider M Minder C 1997 Bias metaanalysis detected Page McKenzie Bossuyt et al 2021 The PRISMA 2020 statement updated simple graphical test BMJ 315 629634 httpsdoiorg101136 bmj3157109629 Evans RM Emsley CL Gao S et al 2000 Serum cholesterol APOE genotype risk Alzheimers disease populationbased study African Americans Neurology 54 240242 httpsdoiorg101212wnl541240 Greenberg SM Vernooij MW Cordonnier C et al 2009 Cerebral microbleeds guide detection interpretation Lancet Neurol 8 165174 httpsdoiorg 101016S1474442209700134 Heringa SM Reijmer YD Leemans A et al 2014 Multiple microbleeds related cerebral network disruptions patients early Alzheimers disease J Alzheimers Dis 38 211221 httpsdoiorg103233JAD130542 guideline reporting systematic reviews BMJ 372 n71 httpsdoiorg101136 bmjn71 Peterson J Welch V Losos M Tugwell PJ 2011 The NewcastleOttawa Scale NOS Assessing Quality Nonrandomised Studies Metaanalyses Ottawa Hospital Research Institute Ottawa 2 pp 112 Poels MMF Ikram MA van der Lugt A et al 2012 Cerebral microbleeds associated worse cognitive function Rotterdam Scan Study Neurology 78 326333 httpsdoiorg101212WNL0b013e3182452928 Romero JR Beiser A Himali JJ et al 2017 Cerebral microbleeds risk incident dementia Framingham Heart Study Neurobiol Aging 54 9499 httpsdoiorg101016jneurobiolaging201702018 Higgins JPT Thomas J Chandler J et al 2019 Cochrane Handbook Systematic Saunders AM Strittmatter WJ Schmechel D et al 1993 Association Reviews Interventions Wiley Jiang Y Wang Y Yuan Z et al 2019 Total cerebral small vessel disease burden related worse performance minimental state examination incident dementia prospective 5year followup J Alzheimers Dis 69 253262 https doiorg103233JAD181135 Khaled Fahim N Negida A 2019 Sample size calculation guide 2 calculate sample size independent cohort study Adv J Emerg Med 3 e12 httpsdoiorg1022114AJEMv0i0104s Kim BJ Lee SH 2013 Cerebral microbleeds associated factors radiologic findings clinical implications J Stroke 15 153163 httpsdoiorg105853 jos2013153153 Kirsch W McAuley G Holshouser B et al 2009 Serial susceptibility weighted MRI measures brain iron microbleeds dementia J Alzheimers Dis 17 599609 httpsdoiorg103233JAD20091073 Maki PM Perschler P Dennerstein L et al 2005 O10102 Hyperlipidemia risk factor cognitive impairment evidence fMRI studies midlife women Alzheimers Dement 1 httpsdoiorg101016jjalz200506277 MartinezRamirez S Greenberg SM Viswanathan A 2014 Cerebral microbleeds overview implications cognitive impairment Alzheimers Res Ther 6 33 httpsdoiorg101186alzrt263 Martins CAR Oulhaj A Jager CA Williams JH 2005 APOE alleles predict rate cognitive decline Alzheimer disease nonlinear model Neurology 65 18881893 httpsdoiorg10121201wnl00001888717409312 Merchant C Tang MX Albert S et al 1999 The influence smoking risk Alzheimers disease Neurology 52 14081412 httpsdoiorg101212 wnl5271408 Miwa K Tanaka M Okazaki S et al 2014 Multiple mixed cerebral microbleeds dementia patients vascular risk factors Neurology 83 646653 https doiorg101212WNL0000000000000692 apolipoprotein E allele epsilon 4 lateonset familial sporadic Alzheimers disease Neurology 43 14671472 httpsdoiorg101212wnl4381467 Shinton R Beevers G 1989 Metaanalysis relation cigarette smoking stroke BMJ 298 789794 Skoog I Lernfelt B Landahl S et al 1996 15year longitudinal study blood pressure dementia Lancet 347 11411145 httpsdoiorg101016s0140 67369690608x Staekenborg SS Koedam ELGE Henneman WJP et al 2009 Progression mild cognitive impairment dementia contribution cerebrovascular disease compared medial temporal lobe atrophy Stroke 40 12691274 httpsdoi org101161STROKEAHA108531343 Starr JM Whalley LJ Inch S Shering PA 1993 Blood pressure cognitive function healthy old people J Am Geriatr Soc 41 753756 httpsdoiorg 101111j153254151993tb07466x Tyas SL White LR Petrovitch H et al 2003 Midlife smoking latelife dementia HonoluluAsia Aging Study Neurobiol Aging 24 589596 https doiorg101016s0197458002001562 van Uden IWM van der Holst HM Tuladhar AM et al 2016 White matter hippocampal volume predict risk dementia patients cerebral small vessel disease RUN DMC study J Alzheimers Dis 49 863873 httpsdoiorg 103233JAD150573 Werring DJ Frazer DW Coward LJ et al 2004 Cognitive dysfunction patients cerebral microbleeds T2weighted gradientecho MRI Brain 127 22652275 httpsdoiorg101093brainawh253 Wu YT Clare L Hindle JV et al 2018 Dementia subtype living results Improving experience Dementia Enhancing Active Life IDEAL study BMC Med 16 140 httpsdoiorg101186s1291601811352 Young SE Mainous AG Carnemolla M 2006 Hyperinsulinemia cognitive decline middleaged cohort Diabetes Care 29 26882693 httpsdoiorg 102337dc060915 IBRONeuroscienceReports142023869494